Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793593 · ClinicalTrials.gov registry record · NA
A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer
A NA study of Colon Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 7
- Study locations
NCT05793593: Active NA study of Colon Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05793593 is a NA study of Colon Cancer Screening that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 80 participants, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05793593, a NA study of Colon Cancer Screening, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Black community has higher rates of colorectal cancer and lower rates of colorectal cancer screenings than whites. Getting screened through FIT testing may help catch colorectal cancer earlier, when it is easier to treat. MSK has created a program to help people who have been FIT tested to also help their peers (family, friends, and colleagues) in their community get FIT tested. The researchers think that training people on peer outreach, such as telling people in your social network about FIT testing and how to get it, may increase the rate of colorectal cancer screening. The purpose of this study is to see if training people on peer outreach increases the number of people who get screened for colorectal cancer through FIT testing.
Conditions Studied
Interventions
- OTHER FITx3 intervention and CRC education
- OTHER Colorectal Cancer (CRC) education alone
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Rockville Centre
New Jersey
- Memoiral Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT05793593 still lists
NCT05793593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Colon Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which FITx3 intervention and CRC education is the first listed.
NCT05793593 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT05793593 about?
NCT05793593 is a clinical study titled "A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer". The Black community has higher rates of colorectal cancer and lower rates of colorectal cancer screenings than whites. Getting screened through FIT testing may help catch colorectal cancer earlier, when it is easier to treat. MSK has created a program to help people who have been FIT tested to also ...
What is the current status of trial NCT05793593?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-03-17. Estimated completion is 2026-03.
What conditions does trial NCT05793593 study?
This clinical trial studies the following conditions: Colon Cancer Screening.
What interventions are being tested in trial NCT05793593?
The interventions under investigation include: FITx3 intervention and CRC education (OTHER), Colorectal Cancer (CRC) education alone (OTHER).
Who is sponsoring clinical trial NCT05793593?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05793593 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy
COMPLETED · NA
-
Patient Reminders Optimizing Mail-in Prevention Testing for Colorectal Cancer
COMPLETED · NA
-
Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments
COMPLETED · NA
-
Colonoscopy Bowel Prep Comparison Among Diabetic Patients
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI